CHE · XBRL financial data
Chemed financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (CHE's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 586* | 589 | 596 | 606 | 640* | 647 | 619 | 625 | 639* | 658 | 673 | 691 |
| Revenue from contracts with customers | 350* | 354 | 375 | 391 | 411* | — | — | — | — | — | — | — |
| Cost of goods and services sold | 358* | 385 | 390 | 396 | 406* | 431 | 434 | 428 | 414* | 442 | 452 | 458 |
| Selling, general and administrative | 100* | 116 | 102 | 102 | 104* | 106 | 100 | 106 | 106* | 114 | 115 | 111 |
| Total operating expenses | year only | 517 | 508 | 514 | 526* | 552 | 551 | 550 | 539* | 573 | 584 | 595 |
| Other operating income (expense) | (0)* | (0) | (0) | (0) | (0)* | (0) | (0) | (0) | (3)* | 0 | (0) | (8) |
| Operating income (loss) | 111* | 72 | 88 | 92 | 114* | 95 | 68 | 75 | 101* | 85 | 89 | 96 |
| Interest expense | 0* | 0 | 0 | 0 | 0* | 0 | 0 | 0 | 1* | 1 | 2 | 2 |
| Other income (expense) | 0* | — | — | 0 | 0* | (0) | 0 | (0) | (0)* | (0) | 0 | 0 |
| Income tax expense (benefit) | 26* | 19 | 23 | 25 | 30* | 24 | 19 | 19 | 29* | 23 | 24 | 25 |
| Net income (loss) | 90* | 65 | 71 | 76 | 90* | 72 | 52 | 64 | 77* | 66 | 68 | 72 |
| Earnings per share, basic USD per share | 5.96* | 4.30 | 4.70 | 5.04 | 6.08* | 4.91 | 3.60 | 4.46 | 5.49* | 4.85 | 5.14 | 5.49 |
| Earnings per share, diluted USD per share | 5.90* | 4.24 | 4.65 | 5.00 | 6.03* | 4.86 | 3.57 | 4.46 | 5.49* | 4.84 | 5.13 | 5.45 |
| Weighted average shares, basic millions of shares | 15* | 15 | 15 | 15 | 15* | 15 | 15 | 14 | 14* | 14 | 13 | 13 |
| Weighted average shares, diluted millions of shares | 15* | 15 | 15 | 15 | 15* | 15 | 15 | 14 | 14* | 14 | 13 | 13 |
Balance sheet
CSVFiscal quarters (CHE's year ends in late December)
Cash flows
CSVFiscal quarters (CHE's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 90* | 65 | 71 | 76 | 90* | 72 | 52 | 64 | 77* | 66 | 68 | 72 |
| Depreciation and amortization | 16* | 16 | 16* | 16* | 16* | 16 | 16* | 16* | 16* | 17 | 17* | 17* |
| Net cash from operating activities | 109* | 85 | 78* | 91* | 165* | 33 | 139* | 83* | 134* | 88 | 85* | 57* |
| Purchases of property and equipment | 12* | 12 | 11* | 14* | 13* | 13 | 16* | 17* | 16* | 17 | 16* | 19* |
| Net cash from investing activities | (12)* | (19) | (93)* | (19)* | (13)* | (14) | (15)* | (14)* | (16)* | (38) | (28)* | (81)* |
| Share repurchases | 40* | 38 | 56* | 58* | 209* | 33 | 43* | 181* | 175* | 190 | 97* | 63* |
| Dividends paid | 6* | 6 | 6* | 7* | 7* | 7 | 7* | 9* | 8* | 8 | 8* | 9* |
| Net cash from financing activities | (6)* | (16) | (74)* | (56)* | (212)* | (24) | (47)* | (189)* | (173)* | (108) | (33)* | 33* |
Compare with peers
SIC 8082 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8082 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Chemed | 48 | 691 | 57* | 13.0M | 10-QSep 30, 2026 |
| Option Care Health | 194 | 1,442 | 184* | 149.8M | 10-QJun 30, 2026 |
| BrightSpring Health Services | 718 | 4,213 | 204* | 199.0M | 10-QSep 30, 2026 |
| Addus HomeCare | 100 | 377 | 40* | 18.7M | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.